MEIP DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds MEI Pharma, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 9, 2020

NEW YORK–(BUSINESS WIRE)–Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against MEI Pharma, Inc. (“MEI Pharma” or “the Company”) (NASDAQ: MEIP) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired MEI Pharma securities in the U.S. between August 2, 2017 and July 1, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: